Art

J-GLOBAL ID：201602210081827887   Reference number：16A0127424

Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma

びまん性大細胞型B細胞リンパ腫の治療前血清中のエプスタイン-バールウイルスのDNA検出の予後診断の意義

Author (15)： OKAMOTO Akinao (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  YANADA Masamitsu (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  MIURA Hiroki (Dep. of Pediatrics, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  INAGUMA Yoko (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  TOKUDA Masutaka (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  MORISHIMA Satoko (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  KANIE Tadaharu (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  YAMAMOTO Yukiya (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  MIZUTA Shuichi (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  AKATSUKA Yoshiki (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  YOSHIKAWA Tetsushi (Dep. of Pediatrics, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  MIZOGUCHI Yoshikazu (Dep. of Pathology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  NAKAMURA Shigeo (Dep. of Pathology and Lab. Medicine, Nagoya Univ. Hospital, Nagoya, JPN) ,  OKAMOTO Masataka (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  EMI Nobuhiko (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN)
Material： Cancer Science (Web)  (Cancer Sci (Web))
Volume： 106  Issue： 11  Page： 1576-1581  Publication year： Nov. 2015 
JST Material Number： U0505A  ISSN： 1349-7006  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： *B cell lymphoma ,...
Semi thesaurus term： small RNA ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A0127424&from=J-GLOBAL&jstjournalNo=U0505A") }}

JST classification (2)： Blood cell tumors(=neoplasms)  (GK04000M) ,  Diagnosis of tumors(=neoplasms)  (GE03020J)

Reference (37)：

• Coiffier B, Lepage E, Briere J et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235-42.
• Sehn LH, Donaldson J, Chhanabhai M et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol 2005; 23: 5027-33.
• Habermann TM, Weller EA, Morrison VA et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 2006; 24: 3121-7.
• Pfreundschuh M, Trumper L, Osterborg A et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 2006; 7: 379-91.
• Pfreundschuh M, Schubert J, Ziepert M et al. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol 2008; 9: 105-16.

Terms in the title (6)： びまん性大細胞型B細胞リンパ腫 ,  治療 ,  血清 ,  ウイルス ,  DNA ,  予後診断